Hong Kong's biopharmaceutical sector experienced a notable recovery as several stocks posted significant gains. According to Jin10, Yiming Angke (01541.HK) surged over 7%, while Deqi Pharmaceutical (06996.HK) rose more than 6%. Additionally, Kangnuoya (02162.HK) and Goli Pharmaceutical (01672.HK) both increased by over 5%, with Laikai Pharmaceutical (02105.HK) also following the upward trend. This positive movement in the market reflects a renewed investor interest in the biopharmaceutical industry.